Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities

Area of Science:

• Bone biology
• Cellular signaling
• Osteoclast differentiation

Background:

• Osteoprotegerin (OPG) is known to regulate bone mass by inhibiting osteoclast activity.
• The precise molecular mechanisms by which OPG affects osteoclast adhesion and podosome dynamics remain unclear.

Purpose of the Study:

• To elucidate the detailed mechanisms underlying OPG-induced changes in osteoclast adhesive structures and signaling.
• To investigate the role of Pyk2 and Src kinases in OPG's effects on osteoclasts.

Main Methods:

• Tartrate-resistant acidic phosphatase staining to assess osteoclast differentiation.
• Scanning electron microscopy, real-time cell monitoring, and confocal microscopy to observe osteoclast morphology and adhesion.
• Western blot analysis to evaluate protein phosphorylation and interactions.

Main Results:

• OPG treatment inhibited osteoclast differentiation and caused time- and dose-dependent retraction of adhesive structures and substrate detachment.
• OPG induced dephosphorylation of Pyk2 at Tyr 402 in peripheral regions and increased its intracellular labeling.
• OPG modulated Src phosphorylation (increased Tyr 416, decreased Tyr 527) and promoted Pyk2/Src association in the central osteoclast region.

Conclusions:

• OPG disrupts osteoclast adhesion by altering the phosphorylation status and subcellular localization of Pyk2 and Src.
• Src may act as an adaptor protein, relocating Pyk2 from the cell periphery to the center, thereby affecting podosome reassembly and detachment.
• These findings provide new insights into the molecular mechanisms of OPG action in regulating bone remodeling.